Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$4.14
-31.9%
$0.00
$0.91
$9.40
$76.40MN/A4.51 million shs64.92 million shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.33
$0.25
$1.24
$17.03M1.19166,266 shs4.12 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.40
+0.4%
$1.10
$0.40
$1.68
$21.99M4.7420,152 shs103,573 shs
Ontrak, Inc. stock logo
OTRK
Ontrak
$1.43
-2.4%
$1.53
$1.27
$5.53
$6.05M2.3452,554 shs25,716 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
0.00%+154.74%-16.31%+348,999,900.00%+348,999,900.00%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%-34.34%-72.69%
Marpai, Inc. stock logo
MRAI
Marpai
0.00%-4.96%+25.81%+39.05%+106.23%
Ontrak, Inc. stock logo
OTRK
Ontrak
0.00%-6.05%-1.01%+2.79%-60.82%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
2.4223 of 5 stars
3.53.00.00.02.50.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
0.00
N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
3.00
Buy$45.003,038.08% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
$10.05M7.60N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.63N/AN/A($1.72) per share-0.81
Ontrak, Inc. stock logo
OTRK
Ontrak
$10.18M0.59N/AN/A$5.56 per share0.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/A0.00N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%6/12/2025 (Estimated)
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$1.82N/AN/A-85.70%N/A-100.23%8/5/2025 (Estimated)
Ontrak, Inc. stock logo
OTRK
Ontrak
-$27.92M-$15.81N/AN/AN/A-237.77%-171.34%-113.42%8/6/2025 (Estimated)

Latest OTRK, BMGL, MRAI, and ENZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.24-$1.65-$0.41-$1.65N/A$2.02 million
4/14/2025Q4 2024
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million
3/17/2025Q2 2025
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A-$0.02N/A-$0.03N/A$7.33 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82
Ontrak, Inc. stock logo
OTRK
Ontrak
0.19
1.17
1.17

Institutional Ownership

CompanyInstitutional Ownership
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%
Ontrak, Inc. stock logo
OTRK
Ontrak
12.95%

Insider Ownership

CompanyInsider Ownership
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
N/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
Marpai, Inc. stock logo
MRAI
Marpai
61.30%
Ontrak, Inc. stock logo
OTRK
Ontrak
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Basel Medical Group Ltd stock logo
BMGL
Basel Medical Group
3618.46 millionN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
Marpai, Inc. stock logo
MRAI
Marpai
15015.71 million5.61 millionNo Data
Ontrak, Inc. stock logo
OTRK
Ontrak
2504.22 million4.14 millionNo Data

Recent News About These Companies

Ontrak reports Q4 EPS ($9.29) vs. ($4.02) last year
Ontrak secures Medicaid provider designation in two new states
ONTRAK INC. DL -,0001 (HY10.DU)
Ontrak Inc (HY10.MU)
Ontrak Inc. (HY10.SG)
Ontrak, Inc. Announces Reverse Stock Split

New MarketBeat Followers Over Time

Media Sentiment Over Time

Basel Medical Group stock logo

Basel Medical Group NASDAQ:BMGL

$4.14 -1.94 (-31.91%)
As of 03:46 PM Eastern

OUR MISSION Basel Medical transcends the role of a conventional healthcare provider. We strive for excellence in medical services and aim to serve as a beacon of hope for patients across Singapore and Southeast Asia. Our mission encompasses the four following commitments: Patient–Centered Care. We prioritize our patient’s wellbeing above all else. Innovation. We strive for excellence through innovation and expertise. Global Accessibility. We believe that quality healthcare should be universally available. Continuous Improvement. We constantly improve our services to meet evolving patient needs. With over 20 years of medical services experience, Basel Medical’s journey began with a simple commitment – to restore healthy and active lifestyles, one at a time. Today, that commitment has transformed into a vision for innovation, growth and far-reaching impact. We rely on an experienced group of medical practitioners to provide a wide spectrum of general and subspecialized orthopedic, trauma, sports medicine and neurosurgical services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, minimally invasive orthopedic procedures and other complex neurosurgical procedures. We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical (together with its subsidiaries, the “Group”), comprising four orthopedic specialists and one neurosurgery specialist. The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities. Our Group has a patient-oriented philosophy of providing personalized, quality and integrated medical care. We aim to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management. Within the next 12 to 18 months, we intend to actively seek acquisition and collaboration partners in Singapore and Malaysia. Our acquisition and collaboration targets include general practitioner (GP) clinics and specialist clinics that complement our orthopedic services, particularly those focused on the musculoskeletal system, aging treatments, physiotherapy and occupational therapists. Our goal is to become an internationally known medical services provider in the Southeast Asian market, with a presence in at least four Southeast Asia countries (potentially covering Singapore, Malaysia, Indonesia and Thailand) within the next three years. As of the date of this prospectus, we have not identified such targets. Basel Medical was incorporated in the BVI on August 10, 2023 with registered number 2129740 as a BVI business company with liability limited by shares. Our BVI registered office is located at Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands VG1110. Our principal executive offices are located in Singapore at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore. Our agent for service of process in the United States is Puglisi & Associates at 850 Library Avenue, Suite 204, Newark, Delaware.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.40 +0.01 (+0.36%)
As of 03:38 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Ontrak stock logo

Ontrak NASDAQ:OTRK

$1.44 -0.03 (-2.11%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.